Transforming Sales & Growth for a National Healthcare Provider

Industry: Healthcare Products & Services

Turnover: Approx. $20 m+

Ownership: Private (Family-Owned)

Project Trigger:

Two years ago, this national healthcare provider, one of Australia’s leading distributors of medical and disability equipment, partnered with Active Directions at a critical point: rising market demand combined with the need to plan for future ownership transition.

In 2024, we worked together to develop a long-term Growth Strategy that set a bold five-year revenue ambition and identified two key priorities: Marketing Excellence and Sales Expansion.

The following year, in 2025, we shifted from strategy to execution, providing hands-on support to the senior management team. This included helping to activate priority initiatives and strengthening internal capability through the recruitment of a Marketing Manager to drive marketing delivery.

By early 2026, revenue growth was tracking upwards, but the sales function was still heavily founder-led and largely unstructured. To sustain momentum and prepare for the future, the client asked us to conduct a sales capability review, refresh their commercial strategy, and design a forward-looking recruitment roadmap aligned to both growth aspirations and eventual exit planning.

This engagement became the catalyst for a comprehensive transformation program that addressed sales performance, organisational capability, and governance to position the business for scalable growth.

Approach

We designed a multi-stream transformation program that delivered not just a plan, but embedded execution. Our work focused on three pillars: Sales Discipline, People & Capacity, and Growth Governance.

1. Building a Disciplined Sales Engine

• Introduced structured sales management rhythms, weekly plan-vs-actual reviews and pipeline governance, giving leadership real-time visibility and control over performance.
• Hands-on coaching of the sales team instilled accountability, cadence, and customer-centric habits through key account planning frameworks.
• Implemented standardised reporting and dashboards to turn data into decisions, creating a predictable, scalable sales model.
  
• Designed a 3-year recruitment roadmap aligned to growth ambitions, addressing succession gaps and critical capacity needs.
• Guided execution: engaged an external recruitment partner, commenced hiring for a National Sales Manager and key roles across marketing, operations, and clinical education.
• Ensured new organisational capability would sustain sales and growth momentum.
• Unified Sales, Marketing, and NPD under one clear growth strategy.
• Refreshed marketing priorities and installed a stage-gate process for new product innovation, ending ad-hoc product decisions in favour of rigor and market alignment.
• Aligned marketing with sales through coordinated campaigns and lead generation strategies targeting priority segments.
  
• Strengthened owner–leadership alignment through formalised governance routines and strategic reporting cadences.
• Launched an Investment/Exit Readiness program, educating shareholders on valuation drivers and capital options.
• Built a high-level roadmap to increase enterprise value and prepare for future sale or investment opportunities.
• From Informal to Disciplined: Sales shifted from reactive to proactive, underpinned by structure, visibility, and forward accountability.
• Ready for Scale: Recruitment planning ensures the right talent will be in place as growth accelerates, starting with the appointment of a dedicated Sales Manager.
• Unified Growth Effort: Sales, marketing, and product development now work in lockstep against a single, integrated strategy.
• Future-Proofed Business: Governance structures and exit readiness give the owners confidence they are building not just a larger business, but a more valuable one.
• Consistent sales governance and account planning routines embedded.
• Marketing and NPD integrated into a single growth engine.
• Structured recruitment underway to strengthen leadership and capacity.
• Shareholders and leadership aligned on strategy, enterprise value, and exit horizon.
  

2. Strategic Workforce Roadmap

• Designed a 3-year recruitment roadmap aligned to growth ambitions, addressing succession gaps and critical capacity needs.
• Guided execution: engaged an external recruitment partner, commenced hiring for a National Sales Manager and key roles across marketing, operations, and clinical education.
• Ensured new organisational capability would sustain sales and growth momentum.
  

 3. Integrated Growth Strategy & Product Governance 

• Unified Sales, Marketing, and NPD under one clear growth strategy.
• Refreshed marketing priorities and installed a stage-gate process for new product innovation, ending ad-hoc product decisions in favour of rigor and market alignment.
• Aligned marketing with sales through coordinated campaigns and lead generation strategies targeting priority segments.
  

4. Governance & Exit Readiness

• Strengthened owner–leadership alignment through formalised governance routines and strategic reporting cadences.
• Launched an Investment/Exit Readiness program, educating shareholders on valuation drivers and capital options.
• Built a high-level roadmap to increase enterprise value and prepare for future sale or investment opportunities.

Outcomes

This engagement has fundamentally reshaped commercial capability. The client now operates with clarity, cadence, and confidence:

Active Directions didn’t just design change; we delivered it side-by-side with the client, building the behaviours, systems, and talent foundations needed for a $30M+ future-ready enterprise.

As a result, a family-owned healthcare provider, once reliant on intuition and founder energy, is now a resilient, growth-focused organisation primed for scale, opportunities, and investor scrutiny.

Starter Questions for Partners and Advisers

1. How confident are you that your current sales capability and capacity can support your growth ambitions over the next 3–5 years?
2. Is your sales function still reliant on a small number of key individuals, or is performance embedded in clear roles, processes, and rhythms?
3. If an investor or acquirer engaged today, how confident would you be in demonstrating disciplined execution, scalable systems, and a credible growth story?